1. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001; 61: 3458-3464.
2.
Saua A, Pellizzari Tregnoa F, Valentinoa F, Federicib G, Caccuria AM. Glutathione transferases and development of new principles to overcome drug resistance. Archives of Biochemistry and Biophysics. 2010; 500(2): 116-122. https://doi.org/10.1016/j.abb.2010.05.012
3.
Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993; 62: 385-427. https://doi.org/10.1146/annurev.bi.62.070193.002125
4.
Clarke FLR. ATP binding cassette transporters and drug resistance in breast cancer. Endoc Relat Cancer. 2003; 10: 43-73. https://doi.org/10.1677/erc.0.0100043
5.
Taniguchi K, Wada M, Kohno K, Kawabe T, Kawakami M, Kagotani K, et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Research.1996; 56: 4124-4129.
6.
Higgins CF. ABC-transporters: from microorganisms to man. Annu Rev Cell Biol. 1992; 8: 67-113. https://doi.org/10.1146/annurev.cb.08.110192.000435
7.
Ishikawa T, JuBao J, Yamane Y, Akimaru K, Frindrich K, Wright CD, et al. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. The Journal of Biological Chemistry. 2000; 271: 14981-14988. https://doi.org/10.1074/jbc.271.25.14981
8.
Cole S, Deeley PC, Roger G. Transport of glutathione and glutathione conjugates by MRP1. Trends in Pharmacological Sciences. 2006; 27(8): 438-446. https://doi.org/10.1016/j.tips.2006.06.008
9.
McLellan LI, Wolf CR. Glutathione and glutathione-dependent enzymes in cancer drug resistance. Drug Resistance Updates. 1999; 2(3): 153-164. https://doi.org/10.1054/drup.1999.0083
10.
Shen H, Kauvar L, Tew KD. Importance of glutathione and associated enzymes in drug response. Oncol Res. 1997; 9: 295-302.
11.
Şimşek G, Oğuztuzun S, Gureşci S, Kilic M, Bozkurt OF, Unsal A. The expression of GST isoenzymes in acinar adenocarcinoma, intraepithelial neoplasia, and benign prostate tissue: correlation of clinical parameters with GST isoenzymes. Turk J Biol. 2012; 36: 687-693. https://doi.org/10.3906/biy-1203-31
12.
Nakanishi Y, Kawasaki M, Bai F, Takayama K, Pei XH, TakanoK, et al. Expression of p53 and glutathione-S-transferase-pi relates to clinical drug resistance in non-small cell lung cancer. Oncology. 1999; 57: 318-23. https://doi.org/10.1159/000012068
13.
Kelley MK, Goldstein AE, Montali JA, Wheatley JB, Schmidt DE, Kauvar LM. Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue. Biochemical Journal. 1994; 304(3): 843-848. https://doi.org/10.1042/bj3040843
14.
Su F, Hu X, Jia W, Gang C, Song E, Hamar P. Glutathione S transferase pi indicates chemotherapy resistance in breast cancer. Journal of Surgical Research. 2003; 113: 102-108. https://doi.org/10.1016/S0022-4804(03)00200-2
15.
Huang J, Tan PH, Thiyagarajan J, Bay BH. Prognostic significance of glutathione S-transferase-Pi in invasive breast cancer. Mod Pathol. 2003; 16(6): 558-565. https://doi.org/10.1097/01.MP.0000071842.83169.5A
16.
Oğuztüzün S, Abu-Hijleh A, Coban T, Bulbul D, Kiliç M, İşcan M, et al. GST isoenzymes in matched normal and neoplastic breast tissue. Neoplasma. 2011; 58(4). https://doi.org/10.4149/neo_2011_04_304
17.
Singh S. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemotherapy and Pharmacology. 2015; 75: 1-15. https://doi.org/10.1007/s00280-014-2566-x
18.
Shenton KC, Dowsett M, Lu Q, Brodie A, Sasano H, Rowlands MG. Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Res Treat. 1998; 49(1): S101-S107. https://doi.org/10.1023/A:1006033813899
19.
Ginsberg G, Susan S, Dale H, Kathryn ZG, Douglas OJ, Babasaheb S. Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. Journal of Toxicology and Environmental Health. 2009; 12(5): 389-439. https://doi.org/10.1080/10937400903158375
20.
Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, et al. MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res. 1996; 2: 1231-1237. https://doi.org/10.1016/0959-8049(96)84850-7
21.
Nooter K, Bruteld lR, Look MP, van Wingerden KE, Henzen Logmans SC, Scheper RJ, et al. The prognostic significance of expression of the multidrug resistance- associated protein (MRP) in primary breast cancer. Br J Cancer. 1997; 76: 486-493. https://doi.org/10.1038/bjc.1997.414
22.
Larkın A, O’drıscoll L, Kennedy S, Purcell R, Moran E, Crown J, et al. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer. A Prognostic Study. J Cancer. 2004; 112: 286-294. https://doi.org/10.1002/ijc.20369
23.
Faneyte IF, Kristel PMP, Maliepaard M, Scheffer GL, Scheper RJ, Schellens JHM, et al. Expression of the breast cancer resistance protein in breast cancer. Clinical Cancer Research. 2002; 8(4): 1068-1074.
24.
Keith WN, Stallard S, Brown R. Expression of MDR1 and GST-pi in human breast tumours: comparison to in vitro chemosensitivity. Br J Cancer. 1990; 61(5): 712-716. https://doi.org/10.1038/bjc.1990.160
25.
Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowant KH. An immunohistochemical study of pi class glutathione s-transferase expression in normal human tissue. American Journal of Pathology. 1990; 137(4): 845-853.
26.
Scheffer GL, Maliepaard M, Pijnenborg ACLM, Gastelen MAV, de Jong MC, Schroeijers AB, et al. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Research. 2000; 60(10): 2589-2593.
Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
